Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatobiliary Diseases”

3,125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,125 results

Not applicableStudy completedNCT05792423
What this trial is testing

Conditionally Increased Output (CIO) Enhanced Ultrasound System

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisFatty Liver
Massachusetts General Hospital 24
Not applicableStudy completedNCT03245580
What this trial is testing

Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)

Who this might be right for
Liver Diseases
Parkview Health 153
Testing effectiveness (Phase 2)WithdrawnNCT02420496
What this trial is testing

Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants

Who this might be right for
CholestasisLiver Disease
The University of Texas Health Science Center at San Antonio
Early research (Phase 1)Study completedNCT04812262
What this trial is testing

DD01 in Overweight/Obese Subjects With T2DM and NAFLD

Who this might be right for
Overweight and ObesityType2 DiabetesNAFLD
Neuraly, Inc. 255
Not applicableUnknownNCT06130202
What this trial is testing

Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Assiut University 165
Large-scale testing (Phase 3)Study completedNCT02584283
What this trial is testing

Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation

Who this might be right for
Liver FailureEnd Stage Liver DiseaseBiliary Tract Diseases
Robert J. Porte 157
Not applicableStudy completedNCT01371396
What this trial is testing

Effect of Dietary Macronutrient Composition

Who this might be right for
Metabolic SyndromeNon-alcoholic Fatty Liver DiseaseObesity
University of Texas Southwestern Medical Center 24
Post-approval studies (Phase 4)Study completedNCT04642261
What this trial is testing

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease
The University of Hong Kong 98
Not applicableStudy completedNCT02647294
What this trial is testing

Polyunsaturated Fatty Acids in Patients With NAFLD.

Who this might be right for
NAFLD
General University Hospital, Prague 60
Testing effectiveness (Phase 2)UnknownNCT02028429
What this trial is testing

Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study.

Who this might be right for
Hepatic Encephalopathy.
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Not applicableLooking for participantsNCT05264051
What this trial is testing

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

Who this might be right for
Liver Diseases
University of Chicago 1,200
Not applicableLooking for participantsNCT06387745
What this trial is testing

Referral of Patients to Hepatology With Hepatoscope

Who this might be right for
Chronic Liver Disease
University Hospital, Antwerp 200
Testing effectiveness (Phase 2)Ended earlyNCT03281083
What this trial is testing

Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Duke-NUS Graduate Medical School 29
Testing effectiveness (Phase 2)Ended earlyNCT04065841
What this trial is testing

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 234
Not applicableStudy completedNCT06398522
What this trial is testing

Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome

Who this might be right for
NAFLDMetabolic Syndrome
University of Bologna 50
Not applicableStudy completedNCT03942822
What this trial is testing

Chia Supplementation and Non Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDietary Modification
Instituto Nacional de Cardiologia Ignacio Chavez 40
Not applicableUnknownNCT04764305
What this trial is testing

Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient a Metabolomics and Proteomics Approach

Who this might be right for
Patient ParticipationHeart Defects, CongenitalLiver Diseases+2 more
Medical University Innsbruck 300
Large-scale testing (Phase 3)Study completedNCT02535195
What this trial is testing

Effect of Ginger Supplement on Non-alcoholic Fatty Liver

Who this might be right for
Non-alcoholic Fatty Liver Disease
Dr Azita Hekmatdoost 60
Testing effectiveness (Phase 2)Study completedNCT04134091
What this trial is testing

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Lipocine Inc. 56
Testing effectiveness (Phase 2)Ended earlyNCT04048876
What this trial is testing

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Who this might be right for
Non-alcoholic Fatty Liver DiseaseLiver Cirrhosis
Celgene 56
Next Page